Drug intelligence / Profile preview

Benzthiazide

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Benzthiazide is a thiazide diuretic used primarily for the treatment of hypertension and edema. It acts by inhibiting the sodium-chloride symporter (Na⁺/Cl⁻ cotransporter) in the distal convoluted tubule of the kidney, leading to increased excretion of sodium and chloride ions. This results in enhanced water loss (diuresis), reduction in blood volume, and subsequently lower blood pressure. Benzthiazide also causes potassium loss via increased exchange with sodium and can increase serum uric acid levels. Its antihypertensive effect may also involve vasodilation through activation of large-conductance calcium-activated potassium channels in vascular smooth muscle and inhibition of carbonic anhydrases within vascular tissue. The drug was developed by Pfizer and marketed under several brand names but is no longer available in some markets such as the United States[1][2][5][6][7].

Brand names
AquatagDihydrexDiucenEdemaxExnaFoven
Other names
benzothiazide
02

Targets

SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)KCNMA1 (Calcium-activated potassium channel subfamily M alpha member 1)CA (Carbonic anhydrase)

Beyond the preview

Go deeper on Benzthiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benzthiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call